Powder: -20°C for 3 years | In solvent: -80°C for 1 year
β-Apo-13-carotenone is a naturally occurring β-apocarotenoid, and is a RXRα antagonist.
Description | β-Apo-13-carotenone is a naturally occurring β-apocarotenoid, and is a RXRα antagonist. |
In vitro | In homogenates of intestinal mucosa of rat, β-apo-13-Carotenone is identified as enzymatic cleavage products of β-carotene. β-apo-13-carotenone is antagonize the activation of RXRα by 9-cis-retinoic acid and is effective at concentrations as low as 1nM. Molecular modeling studies reveal that β-apo-13-carotenone makes molecular interactions like an antagonist of RXRα[1]. β-apo-13-carotenone competes for 9cRA binding to RXRα with an affinity (7–8 nM) identical to 9cRA itself. β-apo-13-carotenone antagonizes 9cRA activation of full-length hRXRα with a similar efficiency as the known antagonist UVI3003. β-apo-13-carotenone induces formation of the RXRα transcriptionally silent tetramer but does not inhibit coactivator recruitment to the isolated LBD[2]. |
Synonyms | D'Orenone |
Molecular Weight | 258.4 |
Formula | C18H26O |
CAS No. | 17974-57-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 33.33 mg/mL (128.99 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
β-Apo-13-carotenone 17974-57-1 Others β Apo 13 carotenone beta-Apo-13-carotenone b-Apo-13-carotenone βApo13carotenone D'Orenone inhibitor inhibit